• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PeerJ . Prediction of influenza A virus-human protein-protein interactions using XGBoost with continuous and discontinuous amino acids information

tetano

Editor, Senior Moderator
PeerJ


. 2025 Jan 30:13:e18863.
doi: 10.7717/peerj.18863. eCollection 2025. Prediction of influenza A virus-human protein-protein interactions using XGBoost with continuous and discontinuous amino acids information

Binghua Li[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Xin Li[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Xiaoyu Li[SUP] 1 2 3 [/SUP], Li Wang[SUP] 1 2 3 [/SUP], Jun Lu[SUP] 4 [/SUP], Jia Wang[SUP] 1 2 3 [/SUP]



Affiliations
Abstract

Influenza A virus (IAV) has the characteristics of high infectivity and high pathogenicity, which makes IAV infection a serious public health threat. Identifying protein-protein interactions (PPIs) between IAV and human proteins is beneficial for understanding the mechanism of viral infection and designing antiviral drugs. In this article, we developed a sequence-based machine learning method for predicting PPI. First, we applied a new negative sample construction method to establish a high-quality IAV-human PPI dataset. Then we used conjoint triad (CT) and Moran autocorrelation (Moran) to encode biologically relevant features. The joint consideration utilizing the complementary information between contiguous and discontinuous amino acids provides a more comprehensive description of PPI information. After comparing different machine learning models, the eXtreme Gradient Boosting (XGBoost) model was determined as the final model for the prediction. The model achieved an accuracy of 96.89%, precision of 98.79%, recall of 94.85%, F1-score of 96.78%. Finally, we successfully identified 3,269 potential target proteins. Gene ontology (GO) and pathway analysis showed that these genes were highly associated with IAV infection. The analysis of the PPI network further revealed that the predicted proteins were classified as core proteins within the human protein interaction network. This study may encourage the identification of potential targets for the discovery of more effective anti-influenza drugs. The source codes and datasets are available at https://github.com/HVPPIlab/IVA-Human-PPI/.

Keywords: GO and KEGG; Influenza A virus; Machine learning; Pathogen-host interaction (PHI); Protein-protein interaction (PPI); XGBoost.

 
Back
Top